---
title: "Movement Disorders"
collection: Disorder
order: 1
permalink: /brain/movementdisorders  

---

I am conducting research focused on identifying biomarkers for movement disorders, with a specific emphasis on **Dystonia** and **Parkinson’s disease**.

| **Type**                       | **Movement Disorder**           | **Description**                                                                      |
|--------------------------------|---------------------------------|--------------------------------------------------------------------------------------|
| **Neurodegenerative**          | Parkinson's Disease             | A progressive neurodegenerative disorder characterized by the degeneration of dopaminergic neurons in the substantia nigra. |
|                                | Huntington's Disease            | A genetic neurodegenerative disorder that leads to the progressive breakdown of nerve cells in the brain.                    |
| **Non-Neurodegenerative**      | Essential Tremor                | A common movement disorder that causes rhythmic shaking, primarily in the hands but can also affect the head, voice, and other parts of the body. |
|                                | Dystonia                        | A movement disorder characterized by sustained muscle contractions, abnormal postures, or twisting movements.                  |
|                                | Tourette Syndrome               | A neurological disorder characterized by repetitive, involuntary movements and vocalizations called tics.                     |
|                                | Ataxia                         | A group of disorders that affect coordination and balance, often resulting from damage to the cerebellum.                     |
|                                | Myoclonus                      | A sudden, brief, and involuntary muscle jerk or spasm.                              |
|                                | Restless Legs Syndrome (RLS)    | A condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations.          |
|                                | Cerebral Palsy                 | A group of disorders that affect movement and muscle tone, often caused by brain damage during early development.             |

This classification highlights the differences between neurodegenerative disorders, which involve progressive degeneration of neurons, and non-neurodegenerative disorders, which may result from various causes and may not lead to progressive neuronal loss.  

Here’s a table summarizing the molecular differences between Dystonia and Parkinson's disease:

| **Aspect**                    | **Dystonia**                                                                                     | **Parkinson's Disease**                                                                          |
|-------------------------------|--------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------|
| **Genetic Factors**           | - Associated with mutations in genes like DYT1 (TOR1A), DYT5 (THAP1), DYT6 (GCH1).            | - Involves mutations in genes such as SNCA (alpha-synuclein), LRRK2, PARK7 (DJ-1), PINK1, and PRKN (parkin). |
|                               | - Inherited in autosomal dominant or recessive manner, affecting basal ganglia circuitry.      | - Genetic mutations lead to dopaminergic neuron dysfunction and synaptic issues.                |
| **Neurotransmitter Systems**  | - Alterations in GABAergic and glutamatergic signaling affecting basal ganglia circuits.       | - Significant loss of dopaminergic neurons in the substantia nigra; decreased dopamine levels.   |
|                               | - Imbalance of neurotransmitters leads to abnormal muscle contractions and postures.           | - Other systems like acetylcholine and serotonin may also be disrupted.                          |
| **Protein Aggregation**       | - Less prominent than in Parkinson's; some studies suggest alterations in stress response proteins. | - Characterized by alpha-synuclein aggregation into Lewy bodies, a hallmark of the disease.     |
|                               | - Mutations in TOR1A affect protein homeostasis and cellular function.                         | - Involves aggregation of other proteins like tau and ubiquitin.                                 |
| **Inflammation and Oxidative Stress** | - Evidence of neuroinflammation with increased cytokines; oxidative stress may contribute to dysfunction. | - Significant neuroinflammation and oxidative stress contribute to dopaminergic neuron degeneration. |
|                               | - Role of oxidative stress is less characterized compared to Parkinson's.                      | - Elevated pro-inflammatory cytokines and microglia activation observed.                         |
| **Metabolic and Mitochondrial Dysfunction** | - Some forms show mitochondrial dysfunction and altered energy metabolism.                    | - Central feature involves mitochondrial dysfunction leading to decreased ATP production and increased oxidative stress. |

This table provides a clear comparison of the molecular differences between Dystonia and Parkinson's disease across several key aspects.
